LABCORP HOLDINGS INC (LH) Stock Price, Forecast & Analysis

USA • New York Stock Exchange • NYSE:LH • US5049221055

276.14 USD
-2.09 (-0.75%)
Last: Feb 6, 2026, 12:07 PM

LH Key Statistics, Chart & Performance

Key Statistics
Market Cap22.89B
Revenue(TTM)13.77B
Net Income(TTM)855.20M
Shares82.90M
Float82.58M
52 Week High293.72
52 Week Low209.38
Yearly Dividend2.91
Dividend Yield1.07%
EPS(TTM)15.82
PE17.46
Fwd PE15.32
Earnings (Next)02-17
IPO1991-04-24
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
LH short term performance overview.The bars show the price performance of LH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

LH long term performance overview.The bars show the price performance of LH in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20 25

The current stock price of LH is 276.14 USD. In the past month the price increased by 9.66%. In the past year, price increased by 12.98%.

LABCORP HOLDINGS INC / LH Daily stock chart

LH Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to LH. When comparing the yearly performance of all stocks, LH is one of the better performing stocks in the market, outperforming 71.69% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

LH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to LH. LH has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LH Financial Highlights

Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 15.82. The EPS increased by 9.71% compared to the year before.


Industry RankSector Rank
PM (TTM) 6.21%
ROA 4.68%
ROE 9.83%
Debt/Equity 0.59
Chartmill High Growth Momentum
EPS Q2Q%19.43%
Sales Q2Q%8.58%
EPS 1Y (TTM)9.71%
Revenue 1Y (TTM)8.28%

LH Forecast & Estimates

29 analysts have analysed LH and the average price target is 305.75 USD. This implies a price increase of 10.72% is expected in the next year compared to the current price of 276.14.

For the next year, analysts expect an EPS growth of 15.38% and a revenue growth 7.75% for LH


Analysts
Analysts82.76
Price Target305.75 (10.72%)
EPS Next Y15.38%
Revenue Next Year7.75%

LH Ownership

Ownership
Inst Owners98.13%
Ins Owners0.31%
Short Float %3.67%
Short Ratio4.27

LH Latest News, Press Relases and Analysis

LH Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
CVS CVS HEALTH CORP10.8396.896B
CI THE CIGNA GROUP9.3776.006B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/2793.9823.171B
DGX QUEST DIAGNOSTICS INC18.4221.391B
GH GUARDANT HEALTH INC N/A12.673B
DVA DAVITA INC10.7610.535B
BTSG BRIGHTSPRING HEALTH SERVICES28.916.918B
CHE CHEMED CORP17.576.42B
OPCH OPTION CARE HEALTH INC17.835.424B

About LH

Company Profile

LH logo image Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Company Info

LABCORP HOLDINGS INC

358 S Main St

Burlington NORTH CAROLINA 27215 US

CEO: Adam H. Schechter

Employees: 70000

LH Company Website

LH Investor Relations

Phone: 13362291127

LABCORP HOLDINGS INC / LH FAQ

What does LABCORP HOLDINGS INC do?

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.


What is the current price of LH stock?

The current stock price of LH is 276.14 USD. The price decreased by -0.75% in the last trading session.


Does LH stock pay dividends?

LABCORP HOLDINGS INC (LH) has a dividend yield of 1.07%. The yearly dividend amount is currently 2.91.


What is the ChartMill rating of LABCORP HOLDINGS INC stock?

LH has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What sector and industry does LABCORP HOLDINGS INC belong to?

LABCORP HOLDINGS INC (LH) operates in the Health Care sector and the Health Care Providers & Services industry.


Is LABCORP HOLDINGS INC (LH) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LH.


What is the outstanding short interest for LABCORP HOLDINGS INC?

The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.67% of its float.